Jyothy Labs reports 3.3% revenue growth for Q2 FY27
Jyothy Labs announced its financial results for the quarter and half-year ended September 30, 2026. The company reported a 3.3% increase in…
Dr Lal PathLabs approves Q2 2026 financials and declares interim dividend
Dr. Lal PathLabs Limited announced the outcome of its Board Meeting held on November 04, 2026. The board approved the un-audited standalone…
Jyothy Labs approves ₹1,470 crore share buyback at ₹215 per share
Jyothy Labs Limited’s Board of Directors has approved a proposal to buy back up to 68,37,210 fully paid-up equity shares. The buyback…
Marksans Pharma posts record quarterly revenue of ₹940 crore
Marksans Pharma has announced its financial results for the second quarter and first half of fiscal year 2027, ending September 30, 2026. The…
Exide Industries encloses investor presentation on Q2 FY27 performance
Exide Industries Limited has submitted its investor presentation for the second quarter of the fiscal year 2026-27 (Q2 FY27). The document…
Jyothy Labs approves ₹1,470 crore equity share buyback
Jyothy Labs Limited has approved a substantial buyback of up to 68,37,210 equity shares, representing approximately 1.86% of its total paid-up…
Dr Lal PathLabs approves interim dividend and invests in Dubai subsidiary
Dr. Lal PathLabs Limited’s Board of Directors has approved the declaration of a second interim dividend of INR 5 per equity share for…
Union Bank of India appoints Dr. Shiv Dayal as new director
Union Bank of India has announced the nomination of Dr. Shiv Dayal as a Part-time Non-Official Director on its Board. This appointment,…
Marksans Pharma reports 30.5% revenue growth for Q2 FY27
Marksans Pharma has announced its financial results for the second quarter and first half of the fiscal year 2027. The company demonstrated…
Redington reports Q2 FY2027 financial results
Redington Limited has announced its unaudited standalone and consolidated financial results for the second quarter and half-year ended…